799557-59-8

Basic information

• Product Name: (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone
• Synonyms: (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone
• CAS NO: 799557-59-8
• Molecular Formula: C₁₃H₂₅N₃O
• Molecular Weight: 0
• Mol File: 799557-59-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone(CAS DataBase Reference)
• NIST Chemistry Reference: (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone(799557-59-8)
• EPA Substance Registry System: (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone(799557-59-8)

Safety Data

• Hazardous Substances Data: 799557-59-8(Hazardous Substances Data)

Usage

Description

(4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone is a synthetic chemical compound that belongs to the class of piperidinyl-benzamides. It possesses potential antipsychotic and anxiolytic activities due to its action on dopamine and serotonin receptors in the brain, which play a crucial role in mood, behavior, and emotion regulation. (4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone may have promising applications in the treatment of psychiatric disorders, although further research is required to fully elucidate its pharmacological properties and therapeutic potential.

Uses

Used in Pharmaceutical Industry:
(4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone is used as a potential therapeutic agent for the treatment of psychiatric disorders such as schizophrenia, bipolar disorder, and anxiety. Its action on dopamine and serotonin receptors may help in managing the symptoms associated with these conditions.
Used in Research and Development:
(4-Cyclobutyl-[1,4]diazepan-1-yl)-piperidin-4-ylmethanone is utilized in research settings to study the effects of piperidinyl-benzamides on the central nervous system and their potential role in the development of novel antipsychotic and anxiolytic medications. Further investigation is necessary to understand its full pharmacological profile and establish its safety and efficacy in clinical applications.

Relevant articles and documents

PIPERAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISEASES

The present invention relates to novel piperidine carbonyl piperazine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.